Alkem Laboratories Ltd. (IN:ALKEM)

:ALKEM

ALKEM

Alkem Laboratories Ltd.

RESEARCH TOOLSreports

Want to see IN:ALKEM full AI Analyst Report?

Alkem Laboratories Ltd. (ALKEM) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALKEM Analyst Ratings

Moderate Buy

2 Buy

1 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Alkem

Laboratories Ltd.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALKEM Stock 12 Month Forecast

Average Price Target

₹6,416.67

▲(15.45% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Alkem Laboratories Ltd. in the last 3 months. The average price target is ₹6,416.67 with a high forecast of ₹6,850.00 and a low forecast of ₹5,900.00. The average price target represents a 15.45% change from the last price of ₹5,558.15.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4804":"₹4,804","6851":"₹6,851","5315.75":"₹5,315.8","5827.5":"₹5,827.5","6339.25":"₹6,339.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6416.666666666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5900,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹5.90K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4804,5315.75,5827.5,6339.25,6851],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5317,5434.923076923077,5552.846153846154,5670.7692307692305,5788.692307692308,5906.615384615385,6024.538461538462,6142.461538461538,6260.384615384615,6378.307692307692,6496.2307692307695,6614.153846153846,6732.076923076923,{"y":6850,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5317,5401.589743589743,5486.179487179487,5570.7692307692305,5655.358974358975,5739.948717948718,5824.538461538462,5909.128205128205,5993.717948717949,6078.307692307692,6162.8974358974365,6247.48717948718,6332.076923076924,{"y":6416.666666666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5317,5361.846153846154,5406.692307692308,5451.538461538462,5496.384615384615,5541.2307692307695,5586.076923076923,5630.923076923077,5675.7692307692305,5720.615384615385,5765.461538461538,5810.307692307692,5855.153846153846,{"y":5900,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5049.413,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4805.533,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4847.674,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5256.851,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5416.464,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5462.939,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5560.204,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5421.771,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5470.825,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5575.5,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5240.45,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5404.05,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5317,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹6,850

Average Price Target₹6,417

Lowest Price Target₹5,900

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Alok Dalal

Jefferies

₹6,500

Buy

16.95%

Upside

Reiterated

05/29/26

Jefferies Remains a Buy on Alkem Laboratories Ltd. (ALKEM)

Bansi Desai

J.P. Morgan

₹5,900

Hold

6.15%

Upside

Reiterated

05/29/26

J.P. Morgan Sticks to Its Hold Rating for Alkem Laboratories Ltd. (ALKEM)

Abdulkader Puranwala

ICICI Securities

₹6,500→₹6,850

Buy

23.24%

Upside

Reiterated

05/28/26

Alkem Laboratories Ltd. (ALKEM) Gets a Buy from ICICI Securities

Damayanti Kerai

HSBC

₹4,910→₹4,850

Hold

-12.74%

Downside

Reiterated

10/14/25

HSBC Reaffirms Their Hold Rating on Alkem Laboratories Ltd. (ALKEM)

Saion Mukherjee

Nomura

₹5,430→₹6,300

Buy

13.35%

Upside

Reiterated

08/22/25

Nomura Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)

Neha Manpuria

Bank of America Securities

₹4,900→₹5,530

Hold

-0.51%

Downside

Upgraded

08/13/25

Bank of America Securities upgrades Alkem Laboratories Ltd. (ALKEM) to a Hold

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Alok Dalal

Jefferies

₹6,500

Buy

16.95%

Upside

Reiterated

05/29/26

Jefferies Remains a Buy on Alkem Laboratories Ltd. (ALKEM)

Bansi Desai

J.P. Morgan

₹5,900

Hold

6.15%

Upside

Reiterated

05/29/26

J.P. Morgan Sticks to Its Hold Rating for Alkem Laboratories Ltd. (ALKEM)

Abdulkader Puranwala

ICICI Securities

₹6,500→₹6,850

Buy

23.24%

Upside

Reiterated

05/28/26

Alkem Laboratories Ltd. (ALKEM) Gets a Buy from ICICI Securities

Damayanti Kerai

HSBC

₹4,910→₹4,850

Hold

-12.74%

Downside

Reiterated

10/14/25

HSBC Reaffirms Their Hold Rating on Alkem Laboratories Ltd. (ALKEM)

Saion Mukherjee

Nomura

₹5,430→₹6,300

Buy

13.35%

Upside

Reiterated

08/22/25

Nomura Sticks to Their Buy Rating for Alkem Laboratories Ltd. (ALKEM)

Neha Manpuria

Bank of America Securities

₹4,900→₹5,530

Hold

-0.51%

Downside

Upgraded

08/13/25

Bank of America Securities upgrades Alkem Laboratories Ltd. (ALKEM) to a Hold

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alkem Laboratories Ltd.

3 Months

Saion MukherjeeNomura

Success Rate

3/3 ratings generated profit

Average Return

+7.77%

Copying Saion Mukherjee's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.77% per trade.

1 Year

Saion MukherjeeNomura

Success Rate

2/3 ratings generated profit

Average Return

+10.00%

Copying Saion Mukherjee's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +10.00% per trade.

2 Years

Saion MukherjeeNomura

Success Rate

2/3 ratings generated profit

Average Return

+5.53%

Copying Saion Mukherjee's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +5.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALKEM Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALKEM has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ALKEM average Analyst price target in the past 3 months is 6,416.67.

Each month's total comprises the sum of three months' worth of ratings.

ALKEM Financial Forecast

ALKEM Earnings Forecast

Next quarter’s earnings estimate for ALKEM is ₹49.10 with a range of ₹49.10 to ₹49.10. The previous quarter’s EPS was ₹19.80. ALKEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.

ALKEM Sales Forecast

Next quarter’s sales forecast for ALKEM is ₹37.95B with a range of ₹37.95B to ₹37.95B. The previous quarter’s sales results were ₹36.03B. ALKEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ALKEM has Performed in-line its overall industry.

ALKEM Stock Forecast FAQ

What is IN:ALKEM’s average 12-month price target, according to analysts?

Based on analyst ratings, Alkem Laboratories Ltd.’s 12-month average price target is 6,416.67.

What is IN:ALKEM’s upside potential, based on the analysts’ average price target?

Alkem Laboratories Ltd. has 15.45% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Alkem Laboratories Ltd. a Buy, Sell or Hold?

Alkem Laboratories Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.

What is Alkem Laboratories Ltd.’s share price target?

The average share price target for Alkem Laboratories Ltd. is 6,416.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹6,850.00 ,and the lowest forecast is ₹5,900.00. The average share price target represents 15.45% Increase from the current price of ₹5,558.15.

What do analysts say about Alkem Laboratories Ltd.?

Alkem Laboratories Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of Alkem Laboratories Ltd.?

To buy shares of IN:ALKEM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Alkem Laboratories Ltd. (ALKEM) Stock Forecast & Price Target

ALKEM Analyst Ratings

ALKEM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alkem Laboratories Ltd.

ALKEM Analyst Recommendation Trends

ALKEM Financial Forecast

ALKEM Earnings Forecast

ALKEM Sales Forecast

ALKEM Stock Forecast FAQ

Detailed List of Analyst Forecasts